International Journal of Gynecological Cancer

Laparoscopy versus laparotomy for benign ovarian tumor: a systematic review and meta-analysis
pp. 387-399(13)
Authors: MEDEIROS,; STEIN,; FACHEL,; GARRY,; FURNESS,

A multi-institutional evaluation of factors predictive of toxicity and efficacy of bevacizumab for recurrent ovarian cancer
pp. 400-406(7)
Authors: WRIGHT,; SECORD,; NUMNUM,; ROCCONI,; POWELL,; BERCHUCK,; ALVAREZ,; GIBB,; TRINKAUS,; RADER,; MUTCH,

The influence of reproductive and hormonal factors on ovarian cancer survival
pp. 407-413(7)
Authors: NAGLE,; BAIN,; GREEN,; WEBB,

A randomized study of screening for ovarian cancer: a multicenter study in Japan
pp. 414-420(7)
Authors: KOBAYASHI,; YAMADA,; SADO,; SAKATA,; YOSHIDA,; KAWAGUCHI,; KANAYAMA,; SHIGETOMI,; HARUTA,; TSUJI,; UEDA,; KITANAKA,

Comorbidity and ovarian cancer survival in Denmark, 1995-2005: a population-based cohort study
pp. 421-427(7)
Authors: TETSCHE,; NØRGAARD,; JACOBSEN,; WOGELIUS,; SØRENSEN,

Prospective evaluation of weekly topotecan in recurrent platinum-resistant epithelial ovarian cancer
pp. 428-431(4)
Authors: LE,; HOPKINS,; BAINES,; RAMBOUT,; FUNG-KEE-FUNG,

An individual prediction of the future (disease-free) survival of patients with a history of early-stage cervical cancer, multistate model
pp. 432-438(7)
Authors: PIETERSE,; KENTER,; EILERS,; TRIMBOS,

The use and understanding of CA125 as a tumor marker for ovarian cancer: a questionnaire-based survey
pp. 439-445(7)
Authors: MOSS,; HOLLINGWORTH,; HOLLAND,; MURPHY,; FERNANDO,; REYNOLDS,

Combination of bleomycin, etoposide, and cisplatin for the treatment of advanced ovarian granulosa cell tumors
pp. 446-452(7)
Authors: PAUTIER,; GUTIERREZ-BONNAIRE,; REY,; SILLET-BACH,; CHEVREAU,; KERBRAT,; MORICE,; DUVILLARD,; LHOMMÉ,

Population-based cohort follow-up study of all patients operated for borderline ovarian tumor in western Sweden during an 11-year period
pp. 453-459(7)
Authors: ÅKESON,; ZETTERQVIST,; DAHLLÖF,; JAKOBSEN,; BRÄNNSTRÖM,; HORVATH,

Phase II multicenter open-label study of karenitecin in previously treated epithelial ovarian and primary peritoneal cancer: a Gynecologic Oncology Group Study
pp. 460-464(5)
Authors: KAVANAGH,; SILL,; RAMIREZ,; WARSHAL,; PEARL,; MORGAN,

Pathology of stage I versus stage III ovarian carcinoma with implications for pathogenesis and screening
pp. 465-469(5)
Authors: YEMELYANOVA,; COSIN,; BIDUS,; BOICE,; SEIDMAN,

Glycomics analysis of serum: a potential new biomarker for ovarian cancer?
pp. 470-475(6)
Authors: LEISEROWITZ,; LEBRILLA,; MIYAMOTO,; AN,; DUONG,; KIRMIZ,; LI,; LIU,; LAM,

Plasticity of ovarian cancer cell SKOV3ip and vasculogenic mimicry in vivo
pp. 476-486(11)
Authors: SU,; FENG,; YAO,; CHENG,; XU,; HUANG,; ZHAO,; JIANG,

Assessment of TP53 mutation using purified tissue samples of ovarian serous carcinomas reveals a higher mutation rate than previously reported and does not correlate with drug resistance
pp. 487-491(5)
Authors: SALANI,; KURMAN,; GIUNTOLI,; GARDNER,; BRISTOW,; WANG,; SHIH,

Significance of E2F-1 overexpression in epithelial ovarian cancer
pp. 492-498(7)
Authors: SUH,; YOON,; CHOI,; KIM,

Expression of hypoxia-inducible factor 1α gene affects the outcome in patients with ovarian cancer
pp. 499-505(7)
Authors: SHIMOGAI,; KIGAWA,; ITAMOCHI,; IBA,; KANAMORI,; OISHI,; SHIMADA,; SATO,; KAWAGUCHI,; TERAKAWA,

Expression of CD133-1 and CD133-2 in ovarian cancer
pp. 506-514(9)
Authors: FERRANDINA,; BONANNO,; PIERELLI,; PERILLO,; PROCOLI,; MARIOTTI,; CORALLO,; MARTINELLI,; RUTELLA,; PAGLIA,; ZANNONI,; MANCUSO,; SCAMBIA,

Effects of anemia correction with epoetin beta in patients receiving radiochemotherapy for advanced cervical cancer
pp. 515-524(10)
Authors: STRAUSS,; HAENSGEN,; DUNST,; HAYWARD,; BURGER,; SCHERHAG,; KOELBL,

Patterns of failure and prognostic factor analyses in locally advanced cervical cancer patients staged by magnetic resonance imaging and treated with curative intent
pp. 525-533(9)
Authors: NARAYAN,; FISHER,; BERNSHAW,

Immunization of mice with plasmids coexpressing HPV16 E5 and the novel oncogene hWAPL
pp. 534-539(6)
Authors: CAO,; MA,; XUN,; XUE,; CHEN,; CHU,

Extracellular regulated kinase-2 immunoreactivity increases in parallel with cervical intraepithelial neoplasia grade in cervical neoplasia
pp. 540-545(6)
Authors: KAPETANIOS,; LAZARIS,; BOGRIS,; KOUNELI,; NONNI,; ARVANITI,; KOURI,; TZAVARA,; GIANNAKODIMOS,; KOUTSELINI,; PATSOURIS,

Prolonged survival among women with BRCA germline mutations and advanced endometrial cancer: a case series
pp. 546-549(4)
Authors: KWON,; LENEHAN,; CAREY,; AINSWORTH,

Peritoneal keratin granulomas complicating endometrial carcinoma: a report of two cases and review of the literature
pp. 549-553(5)
Authors: van derHORST,; EVANS,

Pelvic ganglioneuroma
pp. 553-556(4)
Authors: GUZIN,; AFSAR,; YIGIT,; EREN,; OZERDEN,; KANADIKIRIK,

Radiotherapy in congenital vulvar lymphangioma circumscriptum
pp. 556-559(4)
Authors: YILDIZ,; ATAHAN,; ÖZYAR,; KARCAALTINCABA,; CENGIZ,; OZYIGIT,; AYDIN,; USUBÜTÜN,; AYHAN,

A combination of chemoirradiation and chemotherapy for treatment of advanced clear cell adenocarcinoma of the cervix
pp. 559-563(5)
Authors: CHAN,; IP,; KWONG,; TAM,; NGAN,

High dose single-agent paclitaxel in a hemodialysis patient with advanced ovarian cancer: a case report with pharmacokinetic analysis and review of the literature
pp. 564-570(7)
Authors: BAUR,; FAZENY-DOERNER,; OLSEN,; DITTRICH,

Modified uterine manipulator and vaginal rings for total laparoscopic radical hysterectomy
pp. 571-575(5)
Authors: RAMIREZ,; FRUMOVITZ,; dosREIS,; MILAM,; BEVERS,; LEVENBACK,; COLEMAN,

Vaginal blood flow after radical hysterectomy with and without nerve sparing. A preliminary report
pp. 576-583(8)
Authors: PIETERSE,; TER KUILE,; DeRUITER,; TRIMBOS,; KENTER,; MAAS,

Laparoscopic ovarian transposition in patients with early cervical cancer
pp. 584-589(6)
Authors: PAHISA,; MARTÍNEZ-ROMÁN,; MARTÍNEZ-ZAMORA,; TORNÉ,; CAPARRÓS,; SANJUÁN,; LEJÁRCEGUI,

Erratum
pp. 590-590(1)